-+ 0.00%
-+ 0.00%
-+ 0.00%

LIMINATUS PHARMA ANNOUNCES TRANSFER TO NASDAQ CAPITAL MARKET AND EXTENSION TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT

路透·08/13/2026 11:15:35

登录查看新闻详情